Zentiva obtained a license to AMNIODERM bio patch for chronical wounds healing
Company Zentiva obtained a license to AMNIODERM® bio patch for chronical wounds healing from spin-off company BioHealing of the PrimeCell group to market them on Czech and European market. „We are glad that such an important pharmaceutical producer, like Zentiva is, decided to obtain the license and place AMNIODERM®, biological patch with extraordinary efficacy, developed…
Read more